About
Arcus Biosciences Inc (NYSE:RCUS) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 21 2026
Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2026 Financial Results and Pipeline Updates
Feb 25 2026
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update
Feb 23 2026
Arcus Presents New Data for its HIF-2a Inhibitor Casdatifan, Which Showed Progression-Free Survival Beyond One Year in Late-Line Kidney Cancer
Feb 11 2026
Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2025 Financial Results and Pipeline Updates
Jan 26 2026
Arcus Biosciences Announces New Employment Inducement Grants
Financials
Revenue
$247 M
Market Cap
$2.79 B
EPS
-3.29
Google Übersetzer